Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beam Therapeutics (BEAM) Return on Assets (2020 - 2025)

Beam Therapeutics (BEAM) has disclosed Return on Assets for 6 consecutive years, with 0.06% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 27.0% to 0.06% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.06% through Dec 2025, up 27.0% year-over-year, with the annual reading at 0.06% for FY2025, 23.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.06% at Beam Therapeutics, up from 0.31% in the prior quarter.
  • The five-year high for Return on Assets was 0.06% in Q4 2025, with the low at 0.53% in Q1 2021.
  • Average Return on Assets over 5 years is 0.23%, with a median of 0.22% recorded in 2022.
  • The sharpest move saw Return on Assets soared 38bps in 2022, then dropped -23bps in 2024.
  • Over 5 years, Return on Assets stood at 0.27% in 2021, then rose by 23bps to 0.21% in 2022, then soared by 56bps to 0.09% in 2023, then tumbled by -258bps to 0.33% in 2024, then skyrocketed by 82bps to 0.06% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.06%, 0.31%, and 0.28% for Q4 2025, Q3 2025, and Q2 2025 respectively.